Axovant Sciences (AXON) Defended at Baird on Pfizer Program Discontinuation-Related Selloff

February 2, 2016 1:00 PM

Baird analyst Brian Skorney said while the Pfizer discontinuation of the clinical program for PF-05212377 doesn't have a good read ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found